The Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Mar. 24 announced the initiation of a pivotal global Phase 2 trial of AP26113 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated with crizotinib. The ALTA (ALK in Lung Cancer Trial of AP26113) trial is designed to determine the safety and efficacy of AP26113 in refractory NSCLC patients who test positive for the anaplastic lymphoma kinase (ALK+) oncogene. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares after opening at $8.05 moved to $8.55 on last trade day and at the end of the day closed at $8.52. Company price to sales ratio in past twelve months was calculated as 34.81 and price to cash ratio as 6.69. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) showed a positive weekly performance of 9.79%.
Short interest on Questcor Pharmaceuticals Inc (NASDAQ:QCOR) accounts for 30.3% of the stock’s available float, or 17.49 million shares. It would take about seven sessions to cover these bearish bets, at QCOR’s average pace of trading. Perhaps the equity will see a bout of short-covering activity in the near term, should it continue to climb up the charts.Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shares advanced 6.99% in last trading session and ended the day on $69.47. QCOR return on equity ratio is recorded as 94.20% and its return on assets is 50.60%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) yearly performance is 126.73%.
Plug Power Inc (NASDAQ:PLUG) shares have been ping ponging all over the place for some time, and yesterday they were up again. The big debate on Wall Street is whether we’re seeing a repeat of the technology bust which happened in 2000. Investors have been betting that fuel cells are the future of clean energy—much like they’re betting that Tesla Motors Inc (NASDAQ:TSLA) is the future of clean transportation.Plug Power Inc (NASDAQ:PLUG) shares moved up 6.20% in last trading session and was closed at $7.54, while trading in range of $6.85-$7.68. Plug Power Inc (NASDAQ:PLUG) year to date performance is 386.45%.
Finally, JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) has rallied 6.8% to $10.86, after Northland Securities initiated coverage of the stock with an “outperform” endorsement and $19 price target. Against this backdrop, call volume is running at three times the intraday average, with around 11,000 contracts traded. For comparison, fewer than 200 JASO puts have changed hands. Digging deeper, about half of the action has transpired at the April 11 call, the delta of which has soared to 0.48 from 0.32 at Monday’s close. Affinity for short-term calls marks a change of pace for JASO, as the stock’s Schaeffer’s put/call open interest ratio (SOIR) of 0.97 stands higher than 76% of comparable readings from the past year. In simpler terms, short-term options traders are more put-heavy than usual right now. Still, speculators can purchase JASO’s short-term options at a historical discount, as the equity’s SVI of 61% ranks in the 12th percentile of its annual range. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) weekly performance is 6.67%. On last trading day company shares ended up $11.04. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) distance from 50-day simple moving average is 8.85%. Analysts mean target price for the company is $12.40.
Leave a Reply